Approval · Notice of Compliance 17380 · 2015
AMITIZA: Notice of Compliance 17380
Issued October 14, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17380
- Date
- October 14, 2015
- Company
- Sucampo Pharma Americas LlcBedminster, New Jersey, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMITIZA | 02447363 | Cancelled Pre Market |
Medicinal ingredients
- LUBIPROSTONE 24 MCG per CAP